"Later this year, NanoSomiX will also be introduci
Post# of 30028
Posted On: 01/04/2015 3:01:27 PM
Quote:
"Later this year, NanoSomiX will also be introducing an exosome-based blood test for p-tau, a biomarker for AD that is currently detected only in cerebrospinal fluid and with PET scans."
http://www.nanosomix.com/p3
How does NanoSomiX's exosome-based blood test stack up against Amarantus's blood based bio-marker assay Limpro?
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼